Full Text View
Tabular View
No Study Results Posted
Related Studies
Casodex - Nolvadex Combination
This study has been completed.
Study NCT00637871   Information provided by AstraZeneca
First Received: March 12, 2008   Last Updated: June 11, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gynaecomastia
Prostate Cancer
Additional conditions recognized in this trial
Gynecomastia
Prostatic Neoplasms
More general conditions related to this trial
Breast Diseases
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Skin Diseases
Urogenital Neoplasms
Interventions listed in this trial
Casodex
Tamoxifen
Additional drug interventions recognized in this trial
Bicalutamide
More general drug interventions related to this trial
Androgen Antagonists
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Estrogen Antagonists
Estrogen Receptor Modulators
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Selective Estrogen Receptor Modulators
Therapeutic Uses
Sponsors listed in this trial
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services